First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma
Clinical trial NCT04116658 · COMPLETED
Trial details
- NCT number
- NCT04116658
- Sponsor
- Enterome
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-13
- Primary completion
- 2024-03-04
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.